FDA Approves Pivotal Clinical Trial for Technology to Treat Overactive Bladder
NEW YORK, March 9, 2018 -- (Healthcare Sales & Marketing Network) -- Yesterday, the FDA approved the conduct of a pivotal clinical trial using a new technology to treat overactive bladder. The technology, developed and manufactured by Valencia Technologie... Devices, Urology, FDA Valencia Technologies, overactive bladder, eCoin , neuromodulation
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Brain | Clinical Trials | Marketing | Neurology | Overactive Bladder | Overactive Bladder Syndrome | Pharmaceuticals | Urology & Nephrology